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Cisplatin (CDDP) is widely used for treating solid cancers; however, it induces nephrotoxicity caused 
by oxidative stress. Here, we investigated whether radon inhalation has different effects against CDDP-
induced renal injury in two mouse strains differing in radiosensitivity, and determined the appropriate 
dose of CDDP combined with radon inhalation for highly radiosensitive mice. CDDP was administered at 
20 mg/kg weight to C57BL/6J and BALB/c mice after radon inhalation at 1000 Bq/m3 and 2000 Bq/m3 for 
24 h. Radon inhalation had a slight positive effect against CDDP toxicity in C57BL/6J mice with respect 
to improved hair condition, whereas radon inhalation exacerbated CDDP-induced toxicity in BALB/c 
mice, such as a decrease in hair condition, higher creatinine levels, and decreased antioxidant contents 
(catalase and glutathione). When BALB/c mice were treated with a lower dose of CDDP (15 mg/kg) after 
1000 Bq/m3 radon inhalation, the creatinine level was reduced and the superoxide dismutase content was 
increased, suggesting that this combination might have a protective effect against the CDDP-induced 
renal damage. The supportive effect of radon inhalation shows its good potential as a candidate treatment 
to alleviate CDDP-induced renal damage in veterinary medicine.
INTRODUCTION
Cisplatin (cis-diamminedichloroplatinum II, CDDP) is a widely used chemotherapeutic agent for various 
solid organ tumors such as tumors of the head, neck, testis, 
ovaries, and bladder (Ϛetin et al., 2006; Rana et al., 2016; 
Santos et al., 2007). CDDP is well known to be taken 
up by the proximal tubule cells and accumulates in the 
mitochondria of these cells (Hanigan and Devarajan, 2003; 
Noori and Mahboob, 2010; Prabhu et al., 2013; Uehara et 
al., 2011; Yao et al., 2007). However, CDDP has a toxic 
effect by covalently binding to DNA (Hato et al., 2014). 
Although CDDP also has ototoxicity, gastrotoxicity, and 
myelosuppression, the main dose-limiting toxicity of the 
drug rests in this nephrotoxicity. Oxidative stress has been 
proposed as a key contributing factor to CDDP-induced 
nephrotoxicity (Ozkok and Edelstein, 2014). 
Oxidative stress represents an imbalance between 
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the production of reactive oxygen species (ROS) and their 
removal by antioxidant substances (Galle, 2001). ROS 
such as superoxide (O2
-) are caused by continuous oxygen 
consumption, and are produced within the mitochondria; 
antioxidant substances such as superoxide dismutase 
(SOD), catalase (Cat), and glutathione (GSH) eliminate 
these ROS (Hanigan and Devarajan, 2003; Kruidering et 
al., 1997). However, the uptake of CDDP in cells and their 
subsequent accumulation in the mitochondria induces a 
decrease in the activities of SOD, Cat, and GSH; moreover, 
intracellular GSH levels are further decreased or depleted 
owing to the rapid reaction with CDDP to promote its 
transformation to highly reactive forms (Ozkok and 
Edelstein, 2014; Uehara et al., 2011). This phenomenon 
contributes to the accumulation of ROS, leading to a 
state of oxidative stress within the cell (Pabla and Dong, 
2008). Furthermore, CDDP has been suggested to induce 
mitochondrial dysfunction, and thus ROS are generated 
from the respiratory chains of these malfunctioning 
mitochondria (Kawai et al., 2006; Oh et al., 2016; Ozkok 
and Edelstein, 2014; Pabla and Dong, 2008).
Radon (222 Rn) is a natural radioactive gas that emits 
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α-rays and is absorbed in the body through the lungs via 
respiration as well as through the skin (Kataoka et al., 
2016). Radon is delivered to many tissues through the 
bloodstream and throughout the body (Nishiyama et al., 
2013), and is lipo-soluble with a high amount of energy 
release (Yamato et al., 2013). At the Misasa Medical 
Center of Okayama University Hospital, radon-based 
therapy has been performed using a concentration of 2000 
Bq/m3 and 42°C at room temperature (Sasaoka et al., 
2016). Indications of this therapy are respiratory diseases 
such as bronchial asthma, pain-related diseases such as 
osteoarthritis, and digestive diseases such as chronic 
pancreatitis and gastroenteritis. 
We previously reported that radon inhalation could 
enhance antioxidant function in various organs in mice, 
such as the brain, lung, pancreas, liver, and kidney 
(Kataoka et al., 2011). Moreover, radon inhalation was 
found to mitigate some ROS-related diseases, including 
the effective prevention and treatment of the renal injury 
related to streptozotocin-induced type 1 diabetes and of 
hepatic and renal injuries induced by carbon tetrachloride 
(Kataoka et al., 2011; Nishiyama et al., 2015). Therefore, 
radon inhalation might help to suppress the renal damage 
induced by CDDP owing to its antioxidant functions.
Chronic kidney diseases are observed with a high 
prevalence in geriatric dogs and cats at 0.4–1.5% and 10%, 
respectively (Finch et al., 2016; Fiocchi et al., 2017). Thus, 
the widespread use of CDDP in the treatment of various 
solid tumors in these animals, as well as in humans, is 
associated with a problematic issue of nephrotoxicity 
(Knapp et al., 1987, 1988). In addition, there are several 
types of dog breeds (approximately 400) and cat breeds 
(over 40) (Parker, 2012; Vapalahti, 2016), which differ 
with respect to their risk of developing certain diseases 
such as cardiovascular, hepatic, kidney, and bone and joint 
diseases. Therefore, these strain-specific risks and effects 
of drug administration should be taken into consideration 
in veterinary practice.
In addition, various mouse strains have been used for 
animal experiments, such as C57BL/6J, BALB/c, ICR, 
and Swiss albino mice (Maliakel et al., 2008; Sung et 
al., 2008), and strain-specific differences with respect to 
radio-sensitivity have been documented: C57BL/6J mice 
show relatively low sensitivity, whereas BALB/c mice 
show relatively high sensitivity (Onoue, 1960). However, 
no study has yet directly assessed the difference in this 
sensitivity between strains with respect to the effects 
of radon inhalation on the CDDP-induced renal injury. 
Furthermore, it is important to determine the suitable 
dosage of CDDP administration combined with radon 
inhalation in a highly radiosensitive mouse strain.
Accordingly, the aims of the present study were to 
evaluate whether radon inhalation has different effects on 
CDDP-induced renal injury caused by oxidative stress in 
two different mouse strains differing in radiosensitivity, 
and to determine the effective dosage of CDDP when 
radon inhalation is used. Clarification of these points 
should be beneficial for the appropriate use of CDDP in 
small animals in research and veterinary practice. 
MATERIALS AND METHODS
Animals
Eight-week-old male C57BL/6J mice, weighing 
22.5–26.0 g, and 8-week-old male BALB/c mice, weighing 
23.3–27.0 g, were purchased from Japan Charles River 
Laboratories Inc. (Yokohama, Japan) and housed in clear 
plastic cages with paper-chipping in a temperature (23.2 
± 2.4°C) and light cycle (12 h of light and 12 h of dark)-
controlled room, and maintained on a standard laboratory 
diet with free access to water. Ethical approval for all 
protocols and experiments was obtained from the Animal 
Care and Use Committee of Okayama University. 
Experimental procedure
The evaluation of clinical signs, and measurement of 
urine specific gravity and body weight in each mouse was 
conducted before radon inhalation, at the time of CDDP 
administration, and at 72 h after CDDP administration.
In Experiment 1, C57BL/6J mice and BALB/c mice 
were divided into the following groups with seven mice 
per cage: control group, 1000 Bq/m3 radon inhalation only 
group, 2000 Bq/m3 radon inhalation only group, CDDP 
(20 mg/kg) only group (CDDP 20, sham), CDDP (20 
mg/kg) administration after 1000 Bq/m3 radon inhalation 
group (1000 Bq/m3+CDDP 20), and CDDP (20 mg/kg) 
administration after 2000 Bq/m3 radon inhalation group 
(2000 Bq/m3+CDDP 20).
In Experiment 2, BALB/c mice were divided into 
the following groups with seven mice per cage: control 
group, CDDP (15 mg/kg) only group (CDDP 15, sham), 
CDDP (15 mg/kg) administration after 1000 Bq/m3 radon 
inhalation group (1000 Bq/m3+CDDP 15), and CDDP (15 
mg/kg) administration after 2000 Bq/m3 radon inhalation 
group (2000 Bq/m3+CDDP 15).
After two days of acclimatization, the clinical signs 
were evaluated by calculating the body condition scores 
(BCS) for nutritional assessment according to the criteria of 
the World Small Animal Veterinary Association (Freeman 
et al., 2011): 1, easily palpable ribs and lumbar vertebrae, 
pelvic bones and all bones without detectable body fat 
and muscles; 2, easily visible ribs, lumbar vertebrae, 
pelvic bones, and all bones without palpable body fat and 
with slight loss of muscle; 3, easily palpable ribs without 
palpable fat, visible top of the vertebrae, prominent 
pelvic bones with an obvious waist; 4, easily palpable 
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ribs with slight body fat covering, and easily noticeable 
waist that can be viewed from above; 5, palpable ribs 
without excessive body fat, and an observable waist; 6, 
slight excessive body fat covering the ribs, discernible but 
prominent waist; 7, non-palpable ribs with heavy fat cover, 
obvious fat deposition over the lumbar area, and absent 
or barely visible waist; 8, no palpable ribs due to heavy 
fat cover, fat deposition around the lumbar area, and an 
absent waist; 9, massive fat deposition over the thorax and 
spine, absent waist, and abdominal trunk with heavy fat 
deposition on the neck and limbs. Scale and hair condition 
scores were based on the system described by Miyagawa 
et al. (2013): 0, no scales, 1, a few substantial or systemic 
scales, 2, easily recognized scales systemically, and 3, 
massive scales systemically; and 0, smooth and glossy 
hairs, 1, partially dried hair, 2, systemically dried hair, and 
3, densely tangled and rough hairs, respectively (Fig. 1). 
Urine samples were collected either by the urination at the 
time of the retention of mice or by the bladder pressure of 
the mice for measuring urine specific gravity. Body weights 
in all mice were also recorded at the time of evaluation, 
before radon inhalation and CDDP administration for the 
CDDP groups, and at 72 h after CDDP administration. 
Radon inhalation
Mice were exposed to air only (sham) or radon at the 
specified concentration for 24 h using a radon exposure 
system as previously described (Kataoka et al., 2012). The 
concentration of radon in the mouse cage was supervised 
using a radon monitor (CMR-510, femo-TECH, Inc., OH, 
USA) and adjusted to 1000 Bq/m3 or 2000 Bq/m3. 
CDDP administration
Immediately after radon inhalation, the CDDP groups 
were administered a single dose of CDDP (Wako Pure 
Chemical Industry Co. Ltd., Osaka, Japan) at either 15 mg/
kg body weight or 20 mg/kg body weight intraperitoneally 
(i.p.). The dose was determined so as to be sufficiently high 
to induce severe renal damage in mice (Ueki et al., 2013). 
After treatment, the mice were allowed to acclimate in the 
cages under a similar condition as described above for 72 
h. Since the greatest severity of renal damage was detected 
at 72 h following CDDP i.p. injection, all mice were 
sacrificed by deep diethyl ether anesthesia or inhalation 
of carbon dioxide gas at 72 h after CDDP administration 
(Ueki et al., 2013). 
Biochemical assay
Blood samples were drawn by cardiac puncture at 72 h 
after CDDP injection, and then centrifuged at 3,000 ×g for 
5 min at 4°C. Sera were kept at −80°C until measurement 
of the serum creatinine (Cre) level (as an indicator of renal 
dysfunction) using the Quantichrom Creatinine Assay 
Kit (Funakoshi Co., Ltd., Tokyo, Japan) according to the 
manufacturer’s recommendation. 
Fig. 1. Representative photos of hair condition and scale 
score in mice. A, indicates the normal hair condition and 
scale score of control mice; B, represents each score of hair 
condition; C, each score of scale score.
The left and right kidneys were quickly and surgically 
excised, and the specimens were measured and rinsed in 
10 mM phosphate buffer solution (PBS, pH 7.4) and stored 
at −80°C until analysis of the SOD and Cat activities and 
GSH protein levels. The left kidneys were homogenized 
in 10 mM PBS (pH 7.4) on ice, and the homogenates 
were centrifuged at 12,000 ×g for 45 min at 4°C. The 
supernatants were used for the assay of SOD activity using 
the nitroblue tetrazolium (NBT) reduction method with the 
Wako SOD test (Wako Pure Chemical Industry Co. Ltd., 
Osaka, Japan) according to the manufacturer instructions 
(Baehner et al., 1975).
Effect of Radon Inhalation on Cisplatin-Induced Renal Damage 1159
1160                              
Fig. 2. Effects of radon inhalation on the body condition score (BCS), scale score, and hair condition score in C57BL/6J and 
BALB/c mice with CDDP-induced renal injury. ||| P < 0.001 compares the effects of the radon inhalation group at 2000 Bq/m3 vs. 
the sham group in the C57BL/6J strain. +++P < 0.001 indicates the comparison of the radon inhalation group at 2000 Bq/m3 vs. 
the sham in the BALB/c strain. N.D. means “not detected”. Photographs of mice show the methods for measuring the BCS, scale 
score, and hair condition score.
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 In brief, inhibition of the reduction of NBT was 
measured at 560 nm using a spectrophotometer; one 
unit of enzyme activity was defined as 50% inhibition of 
NBT reduction. Cat activity was measured as the rate of 
hydrogen peroxide (H2O2) reduction at 37°C detected at 
240 nm using a spectrophotometer (Aebi et al., 1976). The 
assay mixture consisted of 50 μL of 1 M Tris–HCl buffer 
containing 5 mM ethylenediaminetetraacetic acid (pH 
7.4), 900 μL of 10 mM H2O2, 30 μL of deionized water, 
and 20 μL of the supernatants of the kidneys. Cat activity 
was calculated using a molar extinction coefficient of 7.1 
× 10-3 M-1cm-1. The GSH content was measured using 
the GSSG/GSH Quantification Kit (Dojindo Molecular 
Technologies Inc., Kumamoto, Japan). In brief, the left 
kidneys were homogenized with 5% 5-sulfosalicylic acid 
and centrifuged at 8,000 ×g for 10 min. The supernatants 
were used for the assay based on the colorimetric reaction 
of GSH by detecting the absorption at 415 nm. Protein 
concentrations were measured using the Bradford method 
with the protein Quantification Kit-Rapid (Dojindo 
Molecular Technologies Inc., Kumamoto, Japan) 
(Bradford, 1976).
Statistical analysis
Data are presented as the mean ± standard error of 
the mean (SEM). The statistical significance of differences 
was determined by t-tests, Mann-Whitney’s U test and 
Kruskal-Wallis test or post-hoc Tukey’s tests or Dunnet 
test for multiple comparisons where appropriate. P < 0.05 
was considered statistically significant.
RESULTS
Clinical signs
In Experiment 1, the BCS tended to be reduced at 
72 h after CDDP administration in all CDDP 20 groups 
compared with the control group for both strains (Fig. 2). 
Scales were recognized in the C57BL/6J strain and the 
scale score tended to be reduced in the 2000 Bq/m3+CDDP 
20 group compared with that of the CDDP 20 group (Fig. 
2). No scales were detected in the BALB/c mice (Fig. 2). 
Similarly, in Experiment 2 using BALB/c mice only with 
a lower CDDP dose (15 kg/mg), the BCS tended to be 
reduced at 72 h after CDDP administration in all groups 
compared with that of the control group (Fig. 3). However, 
there was no difference in the overall BSC between the 
CDDP 15 and CDDP 20 administration groups at 72 h after 
CDDP administration; no scales were observed (Fig. 3).
In the C57BL/6J strain, the hair condition score of the 
2000 Bq/m3+CDDP 20 group was significantly reduced 
compared with that of the CDDP 20 group (P < 0.001; Fig. 
2). By contrast, in the BALB/c strain, the hair condition 
score in the 2000 Bq/m3+CDDP 20 group was significantly 
increased compared with that of the CDDP 20 group (P < 
0.001; Fig. 2). In addition, the hair condition score was 
significantly higher in the 2000 Bq/m3+CDDP 15 group 
than that of the CDDP 15 group (P < 0.001; Fig. 3). 
Fig. 3. Effects of radon inhalation on the body condition 
score (BCS) and hair condition score in BALB/c mice with 
15 mg/kg CDDP-induced renal injury. || |P < 0.001 indicates 
the comparison of the group treated with 15 mg/kg CDDP 
after radon inhalation at 2000 Bq/m3 vs. the sham. N.D. 
means “not detected.” Pictures of mice indicate the method 
of measuring the BCS and hair condition score.
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Fig. 4. Effects of radon inhalation on the influence of 20 mg/kg CDDP administration in body weight, the rate of body weight 
loss, absolute and relative kidney weight, and urine specific gravity in C57BL/6J and BALB/c mice with CDDP-induced renal 
injury. ¶¶¶P < 0.001 compares the data of the treatment groups vs. the control measured at 72 h after CDDP administration in the 
C57BL/6J strain; the sham group received 20 mg/kg CDDP only with air inhalation. †††P < 0.001 indicates the comparison of 
the treatment groups vs. the control in the BALB/c strain at 72 h after CDDP administration. $P < 0.05, $$P < 0.01, $$$P < 0.001 
indicate comparisons of the treatment group vs. the control in the C57BL/6J strain.# P < 0.05, ## P < 0.01, ### P < 0.001 indicate the 
treatment groups vs. the control in the BALB/c strain. §P < 0.05 and §§ P < 0.01 compare data at 72 h after CDDP administration vs. 
before radon inhalation in the C57BL/6J strain. * P < 0.05, ** P < 0.01, and *** P < 0.001 compare the data at 72 h after CDDP 
administration in the treatment groups vs. before radon inhalation in the BALB/c strain. +P < 0.05, ++P < 0.01, and +++P < 0.001 
indicate the CDDP and radon inhalation groups vs. the sham in the BALB/c strain. :P < 0.05 indicates the CDDP and 1000 Bq/m3 
inhalation group vs. the sham in the BALB/c strain.
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Fig. 5. Effects of radon inhalation on the 15 mg/kg CDDP-induced renal injury clinical signs, body weight, the rate of body weight 
loss, absolute and relative kidney weight, and urine specific gravity in BALB/c mice. #P < 0.05, ##P < 0.01, and ###P < 0.001 indicate 
the radon inhalation groups vs. the control. |P < 0.05 indicates the data at 72 h after CDDP administration with 2000 Bq/m3 radon 
inhalation vs. the sham (15 mg/kg CDDP only with air inhalation). +P < 0.05 indicates CDDP administration after 2000 Bq/m3 
radon inhalation vs. the sham.
Body weight, body weight loss, kidney weight, and urine 
specific gravity
Body weight was decreased at 72 h after the 
administration of 20 mg/kg CDDP in all groups compared 
to the control in both strains (P < 0.001; Fig. 4). The rate 
of body weight loss of all groups administered CDDP was 
lower than that of the corresponding control group, with 
no difference from that of the respective sham group in 
both strains (P < 0.001; Fig. 4). Body weight significantly 
decreased in all BALB/c mice treated with 15 mg/kg 
CDDP at 72 h after CDDP administration compared with 
that of the control group (P < 0.001; Fig. 5). In addition, 
the body weight of the 2000 Bq/m3+CDDP 15 group was 
significantly decreased compared with that of the CDDP 
15 group (P < 0.05; Fig. 5). The rate of body weight loss of 
all CDDP 15-administered groups was lower than that of 
the control group (P < 0.001; Fig. 5). 
In C57BL/6J mice, the right kidney weight was 
significantly reduced for all CDDP 20-administered 
groups compared with the control group (P < 0.05; Fig. 4). 
In BALB/c mice, the left kidney weight of the CDDP 20 
group was significantly decreased compared with that of 
the control group (P < 0.05; Fig. 4). The left kidney weight 
of the 1000 Bq/m3+CDDP 20 group was significantly 
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increased compared that of the CDDP 20 group (P < 
0.05; Fig. 4). In C57BL/6J mice, the relative weight of 
the left kidney was significantly increased in all groups 
administered CDDP 20 compared with that of the control 
group (CDDP 20, P < 0.01; 1000 Bq/m3+CDDP 20, P < 
0.001; and 2000 Bq/m3+CDDP20, P < 0.01; Fig. 4). In 
BALB/c mice, the relative weights of both kidneys in the 
1000 Bq/m3+CDDP 20 and 2000 Bq/m3+CDDP 20 groups 
were significantly increased compared with those of the 
control group (left and right kidneys 1000 Bq/m3+CDDP 
20, P < 0.01; right kidney 2000 Bq/m3+CDDP 20, P < 
0.001; and left kidney 2000 Bq/m3+CDDP 20, P < 0.01; 
Fig. 4). The relative weights of the left kidneys of the 1000 
Bq/m3+CDDP 20 and 2000 Bq/m3+CDDP 20 groups were 
also significantly higher than that of the CDDP 20 group 
(1000 Bq/m3+CDDP 20, P < 0.001; 2000 Bq/m3+CDDP 
20, P < 0.01; Fig. 4). As shown in Figure 5, kidney weight 
was also significantly reduced in the left kidneys of the 
CDDP 15 and 1000 Bq/m3+CDDP 15 groups compared 
with that of the control group (both P < 0.05). Moreover, 
the absolute and relative weights of both kidneys in the 
2000 Bq/m3+CDDP 15 group were increased compared 
with those of the CDDP 15 group (P < 0.05; Fig. 5) and 
control group (P < 0.01; Fig. 5). 
The urine specific gravities of the CDDP 20 and 2000 
Bq/m3+CDDP 20 groups were significantly lower than that 
measured before radon inhalation in C57BL/6J mice (P < 
0.01 and P < 0.05, respectively; Fig. 4). In BALB/c mice, 
the urine specific gravities of all groups administered 
CDDP at 20 mg/kg were significantly decreased compared 
with that of the control group (P < 0.001; Fig. 4), and were 
significantly lower at 72 h after CDDP administration 
than that measured before radon inhalation (CDDP 20, P 
< 0.05; 1000 Bq/m3+CDDP 20, P < 0.01; and 2000 Bq/
m3, P < 0.001; Fig. 4). The urine specific gravity of the 
1000 Bq/m3+CDDP 20 group was significantly decreased 
compared to that of the CDDP 20 group at 72 h after CDDP 
administration (P < 0.05; Fig. 4). Urine specific gravities 
of all groups treated with CDDP 15 were lower than that 
of the control group (P < 0.001; Fig. 5), and the urine 
specific gravity of the 2000 Bq/m3+CDDP 15 group was 
also significantly lower than that of the CDDP 15 group (P 
< 0.05; Fig. 5).
 
Index of renal injury
To estimate the ability of radon inhalation to mitigate 
the renal injury induced by CDDP, Cre levels were 
determined as an index of renal injury. In C57BL/6J mice, 
there were no significant differences in Cre levels among 
any of the CDDP-treated mice. In BALB/c mice, the Cre 
levels of all CDDP-administered groups were significantly 
higher than that of control mice (CDDP 20 P < 0.05; 1000 
Bq/m3+CDDP 20, P < 0.05, and 2000 Bq/m3, P < 0.01; Fig. 
6A), with no difference among the three CDDP-treated 
groups (Fig. 6A). The Cre levels of the CDDP 15 and 2000 
Bq/m3+CDDP 15 groups tended to be increased compared 
with those of the controls (Fig. 7A). However, there was 
a decrease in Cre of approximately 70% in the 1000 Bq/
m3+CDDP 15 group compared with that of the CDDP 15 
group (Fig. 7A). 
Effect of radon inhalation on renal antioxidant-related 
substances
To assess the antioxidative effect of radon inhalation 
against CDDP-induced renal injury, the antioxidant-related 
substances SOD, Cat, and GSH were analyzed. 
The SOD activity of the CDDP 20 group was 
significantly decreased compared with that of the control 
group in C57BL/6J mice (P < 0.05; Fig. 6B). In BALB/c 
mice, the SOD activity of the 2000 Bq/m3+CDDP 20 group 
was significantly lower than that of the control group (P < 
0.01; Fig. 6B), whereas the SOD activity of the 1000 Bq/
m3+CDDP 20 group was significantly increased compared 
with that of the CDDP 20 group (P < 0.001; Fig. 6B). 
Similarly, the SOD activity of the 2000 Bq/m3 +CDDP 15 
group was significantly decreased compared with that of 
the control mice (P < 0.01; Fig. 7B), whereas the activities 
of both the 1000 Bq/m3+CDDP 15 and 2000 Bq/m3+CDDP 
15 groups were significantly increased compared with that 
of the CDDP 15 group (both P < 0.05; Fig. 7B).
The Cat activities of all CDDP administration groups 
were significantly lower than that of control mice (P < 
0.005; Fig. 6B), and there were no significant differences 
among the CDDP administration groups in C57BL/6J 
mice. However, in BALB/c mice, Cat activities were 
significantly decreased in the 1000 Bq/m3+CDDP 20 and 
2000 Bq/m3+CDDP 20 groups compared with that of 
the control group (P < 0.05 and P < 0.01, respectively) 
(Fig. 6B) and CDDP 20 group (P < 0.05 and P < 0.001, 
respectively) (Fig. 6B). Similarly, the Cat activity of the 
2000 Bq/m3 +CDDP 15 group was significantly lower than 
that of the control group (P < 0.01; Fig. 7B) and CDDP 15 
group (P < 0.001) (Fig. 7B).
In C57BL/6J mice, the GSH activity of the 2000 Bq/
m3+CDDP 20 group was 30% higher than that of the CDDP 
20 group. However, in BALB/c mice, the GSH activities 
were significantly decreased in all CDDP-administered 
groups compared with that of the control group (P < 0.01; 
Fig. 6B), and the 2000 Bq/m3+CDDP 20 group showed a 
26% decrease in GSH activity compared with that of the 
CDDP 20 group (Fig. 6B). In addition, the GSH activity of 
the 2000 Bq/m3 +CDDP 15 group showed a 52% decrease 
compared with that of CDDP15 group (Fig. 7B).
1165                              Effect of Radon Inhalation on Cisplatin-Induced Renal Damage 1165
Fig. 6. Effects of radon inhalation on the influence of 20 mg/kg CDDP administration on A) the serum creatinine level, and 
B) antioxidant-related substances in C57BL/6J and BALB/c mice with CDDP-induced renal injury. $P < 0.05 and $$$P < 0.001 
indicate the treatment groups vs. the control in the C57BL/6J strain. The sham group represents the group administered with 20 
mg/kg CDDP only with air inhalation. #P < 0.05, ## P < 0.01, and ### P < 0.001 indicate the treatment groups vs. the control in the 
BALB/c strain. +P < 0.05 and +++P < 0.001 indicate the radon inhalation groups vs. the sham in the BALB/c strain.
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Fig. 7. Effects of radon inhalation on the changes in 
A) serum creatinine level and B) antioxidant-related 
substances caused by 15 mg/kg CDDP in BALB/c mice 
with CDDP-induced renal injury. ##P < 0.01 indicates the 
treatment groups vs. the control. The sham group was 
treated with 15 mg/kg CDDP only with air inhalation. |P < 
0.05 and || |P < 0.001 indicate the radon inhalation groups 
vs. the sham.
DISCUSSION 
Radon inhalation has been suggested to enhance the 
antioxidant functions of various organs such as the brain, 
lung, heart, liver, and kidney (Kataoka et al., 2011), and 
ROS-related diseases of these organs have been shown 
to be inhibited via the suppression of ROS activity. 
Furthermore, radon inhalation was found to effectively 
improve clinical signs in a study with a renal kidney failure 
animal model (Kataoka et al., 2012). Although CDDP is 
an effective chemotherapeutic agent, various side effects 
have been confirmed, including nephrotoxicity as a major 
adverse effect. The overarching aim of the present study 
was to evaluate the different effects of radon inhalation 
on mediating this CDDP-induced renal damage in two 
different radiosensitivity mouse strains and to determine 
an appropriate CDDP dose in combination with radon 
inhalation in the highly radiosensitive mouse strain.
Our results revealed no notable differences between 
strains with respect to BCS, body weight, and the rate of 
body weight loss upon 20 mg/kg CDDP administration 
with or without radon inhalation at two concentrations. 
Body weight loss is a common outcome of cancer therapy, 
and therefore nutrition management is an important 
consideration (Nakahara et al., 2012). Accordingly, both 
body weight loss and the rate of this loss are important 
factors for accurately assessing the effect of CDDP. 
Body weight loss arises from the gastrointestinal toxicity 
in response to CDDP treatment, and the consequent 
reduction of food intake leads to a poor nutritional status 
(Noori and Mahboob, 2010; Rana et al., 2016). The BCS 
reflects the nutritious condition of animals (Freeman et al., 
2011). Therefore, it is considered that the poor nutrition 
condition observed in C57BL/6J and BALB/c mice was 
caused by the gastrointestinal toxicity from 20 mg/kg 
CDDP administration. However, radon inhalation could 
not protect against this gastrointestinal toxicity. With 
respect to dose, gastrointestinal toxicity was detected with 
the administration of both 15 mg/kg and 20 mg/kg CDDP 
in combination with radon inhalation at 2000 Bq/m3 given 
the reductions in the BCS, body weight, and rate of body 
weight loss, indicating that even a relatively high radon 
concentration (2000 Bq/m3) cannot suppress the reduction 
of food intake due to the gastrointestinal toxicity induced by 
CDDP administration at both doses evaluated in this study. 
Poor hair quality with an increase of scales is 
commonly observed in animals suffering from renal injury 
(Canon, 2016). Therefore, we also evaluated the hair 
condition as well as scale scores as clinical signs of renal 
injury induced by CDDP to evaluate the effects of radon 
inhalation. The results showed that both the hair condition 
and scale scores were improved in mice administered with 
20 mg/kg CDDP after 2000 Bq/m3 radon inhalation in the 
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C57BL/6J strain, suggesting that this radon concentration 
may mitigate the CDDP-induced renal injury in this strain. 
By contrast, the hair condition further deteriorated in 
BALB/c mice that received 20 mg/kg CDDP after 2000 
Bq/m3 radon inhalation, suggesting that a relatively high 
radon concentration may exacerbate the CDDP-induced 
renal damage, which is a mark of the high radiosensitivity 
of this strain. This same effect was noted with 15 mg/
kg CDDP administration, indicating that the extent of 
renal damage induced by CDDP administration may 
be aggravated by the combination with a high radon 
concentration regardless of the CDDP dose. 
CDDP-treated animals also show polyuria, indicating 
a reduction in the urine specific gravity because of a 
deficiency of urine concentration (Ecelbarger et al., 
2001; Nematbakhsh et al., 2013). Polyuria was confirmed 
following 20 mg/kg CDDP administration after inhaling 
2000 Bq/m3 radon in C57BL/6J mice, and all BALB/c 
mice administered either 20 mg/kg or 15 mg/kg CDDP 
after radon inhalation showed significant reductions of 
urine specific gravity, indicating that radon inhalation 
does not mitigate the renal damage induced by CDDP. 
Specifically, there was a significant reduction of urine 
specific gravity with 15 mg/kg CDDP administration after 
2000 Bq/m3 radon inhalation and with 20 mg/kg CDDP 
after both 1000 Bq/m3 and 2000 Bq/m3 radon inhalation. 
These findings suggest that the combination of 15 mg/kg 
CDDP administration and 2000 Bq/m3 radon inhalation 
and the combination of 20 mg/kg CDDP administration 
and 1000 Bq/m3 and 2000 Bq/m3 radon inhalation does not 
provoke the polyuria in CDDP-induced renal damage. 
The severity of renal damage can be indicated 
by a larger kidney weight (Nematbakhsh et al., 2013; 
Tokunaga et al., 1996). This enlargement of the kidney 
is not due to a relative effect linked to overall weight 
loss but rather results from edema caused by necrosis in 
the tubular cells (Rana et al., 2016). Therefore, both the 
absolute and relative kidney weights should be considered 
for assessments of the ability of radon inhalation to 
improve the CDDP-induced renal injury. The present 
study showed that absolute and relative kidney weights 
increased in the C57BL/6J mice administered 20 mg/kg 
CDDP after radon inhalation, indicating that the edema 
of the tubular cells in these kidneys was indeed induced 
by CDDP and could not be mitigated by radon inhalation. 
Similarly, the BALB/c mice showed significant increases 
in both the absolute and relative kidney weights with 20 
mg/kg CDDP administration after radon inhalation at 
both concentrations, suggesting that radon inhalation 
might actually worsen the necrosis of tubular cells in 
the kidneys in this strain. The kidney is considered to 
be a relatively weakly radiosensitive organ based on the 
different radiosensitivities in various tissues and organs. 
Furthermore, radon is a highly lipo-soluble substance 
(Yamato et al., 2013); therefore, it would be expected 
that radon inhalation would have minimal effects on renal 
injury in these strains since the kidney has less fat than 
the other organs. The kidney weights of BALB/c mice also 
increased with the combination of 15 mg/kg CDDP and 
2000 Bq/m3 radon, as well as 20 mg/kg CDDP and both 
1000 Bq/m3 and 2000 Bq/m3 radon inhalation, suggesting 
that these combinations could further exacerbate the 
CDDP-induced renal injury. 
Cre is filtered out of the body by the kidneys, and 
the level of Cre increases when the filtration function of 
the kidney is damaged (Prabhu et al., 2013). Likewise, the 
serum Cre level is elevated with increasing histological 
damage to the tubular cells (Palipoch and Punsawasd 
2013). We did not detect an effect of radon inhalation at 
either concentration on the Cre level in C57BL/6J mice, 
indicating that radon inhalation cannot inhibit the effects 
of CDDP on renal damage in this strain due to its low 
radiosensitivity. However, in the BALB/c strain, the Cre 
levels actually increased with 20 mg/kg CDDP after radon 
inhalation at both concentrations, suggesting that the high 
radiosensitivity of this strain resulted in exacerbation of 
the CDDP-induced renal damage by radon inhalation in 
radon inhalation. Evaluation of the influence of CDDP 
dose showed that 1000 Bq/m3 radon inhalation reduced the 
Cre level with administration of 15 mg/kg CDDP, but not 
significantly, indicating that radon inhalation may increase 
the glomerular filtration rate so that the renal injury is 
mitigated by a relatively low radon concentration (1000 
Bq/m3). 
Given this decrease in the Cre level, we further 
examined antioxidant activity in the C57BL/6J and 
BALB/c strains and at different CDDP administration 
doses in the BALB/c strain. SOD converts O2
- to hydrogen 
peroxidase (H2O2), whereas Cat and GSH transform H2O2 
to water (H2O) and then to oxygen (O2) (Sasaoka et al., 
2016). In addition, O2
- is generated by consuming oxygen 
in the mitochondria (Kruidering et al., 1997); indeed, 
O2
- is mainly generated from the respiratory chain in the 
mitochondria (Kruidering et al., 1997; Pabla and Dong, 
2008). It has also been suggested that CDDP decreases 
the activity of antioxidants after accumulating in the 
mitochondria (Noori and Mahboob, 2010). In the present 
study, the GSH content tended to increase in the C57BL/6J 
strain after 2000 Bq/m3 radon inhalation. This suggests 
that GSH plays an important role for the mitigation of the 
CDDP-induced renal injury in C57BL/6J mice. However, 
since this difference was not statistically significant, the 
effect of radon inhalation in this strain may be small. By 
contrast, in the BALB/c strain, although the SOD activity 
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showed an increase in the GSH level following 1000 Bq/
m3 radon inhalation, it was reduced following 2000 Bq/
m3 radon inhalation with 20 mg/kg CDDP administration. 
The radon concentration employed in this study was 
determined according to the reference of the radon therapy 
used at Misasa Medical Center, Okayama University, and 
based on our previous study examining the change in 
SOD activity in the kidneys of BALB/c mice (Kataoka 
et al., 2011). In this previous study, the SOD activity in 
the kidney sharply increased at 24 h, decreased at 72 h, 
and then gradually increased with 1000 Bq/m3 radon 
inhalation. However, the SOD activity did not increase 
at 24 h and remained constant with 2000 Bq/m3 radon 
inhalation. Therefore, the low SOD activity observed with 
2000 Bq/m3 radon inhalation in the present study likely 
reflects these dynamics. Consequently, the inhalation of 
2000 Bq/m3 radon may not contribute to the mitigation of 
CDDP-induced renal injury in this strain. In addition, Cat 
activity and the GSH contents were significantly reduced 
following 1000 Bq/m3 and 2000 Bq/m3 radon inhalation. 
As mentioned above, antioxidant activity was enhanced at 
about 24 h and the effect was reduced by radon inhalation 
at 72 h (Kataoka et al., 2011). Therefore, these reductions 
of Cat activity and GSH content with 20 mg/kg CDDP 
administration might be due to this sequential change 
in these antioxidants. Moreover, our results showed that 
SOD activity was significantly high with the combination 
of 15 mg/kg CDDP and 1000 Bq/m3 radon inhalation, 
suggesting that the function of the antioxidant SOD was 
enhanced by the radon inhalation. This finding is in line 
with the results of our previous study demonstrating the 
change of SOD activity in the kidneys of BALB/c mice 
(Kataoka et al., 2011). Therefore, SOD activity may 
contribute to the mitigation of 15 mg/kg CDDP-induced 
renal injury conferred by 1000 Bq/m3 radon inhalation. 
Furthermore, according to the analysis of antioxidant 
activity in paratuberculosis positive cattle, there were no 
variation of SOD and GSH-PX activities in their sera. Since 
radon inhalation enhances the antioxidative function, the 
elevation of antioxidant activity for the biological defense 
system against the infection might be observed in these 
cattle after radon exposure (Cenesiz et al., 2016).
Although we used healthy mice for evaluating the 
effects of radon inhalation against the CDDP induced renal 
damage model in this study, the further study are needed to 
assess the effects of radon inhalation with the combination 
of various CDDP dose and radon concentration in the 
cancer mouse model. 
CONCLUSION
In conclusion, evaluation of the differences in clinical 
signs, indexes of renal injury, and antioxidant activities 
suggests strain-specific effects of radon inhalation on 
CDDP-induced renal damage, with clear differences 
detected between C57BL/6J and BALB/c mice. These 
differences are assumed to result from intrinsic variations in 
the radiosensitivities of these strains. C57BL/6J mice have 
relatively low radiosensitivity characteristics, indicating 
that the effects of radon inhalation on CDDP-induced 
renal damage would be minimal, whereas BALB/c mice 
have relatively high radiosensitivity, and exhibited high 
sensitivity to radon inhalation, which may be associated 
with radiation-induced DNA damage to further exacerbate 
the CDDP-induced renal damage. Moreover, comparison of 
the CDDP administration dose in BALB/c mice suggested 
that the combination of 15 mg/kg CDDP and 1000 Bq/m3 
radon inhalation is likely to protect against CDDP-induced 
renal damage to some extent via increasing the SOD 
content. Based on these results, radon inhalation appears 
to be a suitable candidate for further studies of mitigating 
CDDP-induced renal injury in veterinary practice. 
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